Copper-zinc superoxide dismutase (Cu,Zn-SOD) plays a protective role in various types of tissue protecting them from oxidative damage. Alterations in Cu,Zn-SOD (SOD1 and SOD3) activity and its expression have been observed in pathological occurrences most prevalent in modern society, including inflammatory bowel disease, obesity and its implications—diabetes and hypertension, and chronic obstructive pulmonary disease. Moreover, several SOD1 and SOD3 gene polymorphisms have been associated with the risk of developing a particular type of disease, or its exacerbation. This article features recent observations in this topic, aiming to show the importance of proper gene sequence and activity of Cu,Zn-SOD in the aforementioned diseases.
CITATION STYLE
Lewandowski, Ł., Kepinska, M., & Milnerowicz, H. (2019, January 1). The copper-zinc superoxide dismutase activity in selected diseases. European Journal of Clinical Investigation. Blackwell Publishing Ltd. https://doi.org/10.1111/eci.13036
Mendeley helps you to discover research relevant for your work.